BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2779754)

  • 1. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex.
    Norman AB; Blaker SN; Thal L; Creese I
    Neurosci Lett; 1986 Oct; 70(2):289-94. PubMed ID: 3774231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
    Vige X; Briley M
    Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex.
    Meyer EM; Arendash GW; Judkins JH; Ying L; Wade C; Kem WR
    J Neurochem; 1987 Dec; 49(6):1758-62. PubMed ID: 3681294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites.
    Araujo DM; Lapchak PA; Meaney MJ; Collier B; Quirion R
    J Neurosci; 1990 Sep; 10(9):3069-78. PubMed ID: 2398371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
    Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
    Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.
    Schwartz RD; Kellar KJ
    J Neurochem; 1985 Aug; 45(2):427-33. PubMed ID: 4009168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain.
    Quirion R
    Synapse; 1987; 1(4):293-303. PubMed ID: 3138770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function.
    Lapchak PA; Araujo DM; Quirion R; Beaudet A
    Brain Res; 1990 Aug; 525(2):249-55. PubMed ID: 2253030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cholinergic but not in GABAergic markers in amygdala, piriform cortex, and nucleus basalis of the rat brain following systemic administration of kainic acid.
    Schliebs R; Zivin M; Steinbach J; Rothe T
    J Neurochem; 1989 Jul; 53(1):212-8. PubMed ID: 2542459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nucleus basalis lesion on muscarinic receptor subtypes.
    Bogdanovic N; Islam A; Nilsson L; Bergström L; Winblad B; Adem A
    Exp Brain Res; 1993; 97(2):225-32. PubMed ID: 8150042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical studies of oxiracetam (CT-848) on cholinergic neurons].
    Mochizuki D; Sugiyama S; Shinoda Y
    Nihon Yakurigaku Zasshi; 1992 Jan; 99(1):27-35. PubMed ID: 1559636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding.
    Morin AM; Wasterlain CG
    Neurochem Res; 1980 Mar; 5(3):301-8. PubMed ID: 7374884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of receptor-coupled phosphoinositide hydrolysis in the rat hippocampus after intradentate colchicine.
    Tandon P; Ali SF; Bonner M; Tilson HA
    J Neurochem; 1989 Oct; 53(4):1117-25. PubMed ID: 2549197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study.
    Atack JR; Wenk GL; Wagster MV; Kellar KJ; Whitehouse PJ; Rapoport SI
    Brain Res; 1989 Apr; 483(2):367-72. PubMed ID: 2706526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: new findings and an interpretative review.
    Sherman KA; Friedman E
    Int J Dev Neurosci; 1990; 8(6):689-708. PubMed ID: 2288244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.